Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
RAPT
#1869
RAPT Therapeutics Inc
58.020
0
USD
+0.07%
Sektor:
Gesundheitswesen
Basis:
USD
Gewinnwährung:
USD
Tagesspanne
Jahresspanne
Tagesänderung
+0.07%
Monatliche Änderung
+0.38%
6 month change
+0.38%
Jahresänderung
+0.38%
Vorheriger Schlusskurs
57.980
0
Open
58.020
0
Bid
58.020
0
Ask
58.023
0
Low
58.020
0
High
58.020
0
Volumen
47
Märkte
Aktien
Gesundheitswesen
RAPT
Open full chart
Financials
Overview
Finanzbericht
Statistics
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
4.37 M
16.5 M
16.54 M
16.54 M
27.71 M
—
Valuation ratios
Enterprise value
—
—
—
90.42 M
676.73 M
—
Price to earnings ratio
—
—
—
-0.54
-2.21
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
1
5.29
—
Price to book ratio
—
—
—
0.11
0.46
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.17
0.22
0.09
0.1
0.11
0.52
Return on equity %
0.19
0.28
0.1
0.11
0.12
0.6
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
9.9
4.87
21.11
13.25
12.04
51.27
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
3.62
2.05
1.95
0.42
0.46
4.88
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
20.13
45.36
6.66
6.27
5.83
64.12
Net current asset value per share
21.1
46.17
6.8
6.41
5.97
65.36
Tangible book value per share
19.64
37.27
6.59
6.1
5.64
55.6
Working capital per share
18.97
36.68
6.48
5.93
5.48
54.57
Book value per share
19.64
37.27
6.59
6.1
5.64
55.6
Nachrichten
GSK übernimmt RAPT Therapeutics für 2,2 Milliarden US-Dollar
GSK schließt Übernahme von RAPT Therapeutics für 2,2 Milliarden US-Dollar ab
GSK completes $2.2 billion acquisition of RAPT Therapeutics
GSK vollzieht Übernahme von RAPT Therapeutics, Delisting von der NASDAQ folgt
RAPT Therapeutics-Aktie erreicht 52-Wochen-Hoch bei 57,98 $
RAPT Therapeutics stock hits 52-week high at $57.98
GSK-Übernahme treibt Aktie von Rapt Therapeutics auf neues Jahreshoch
Rapt Therapeutics stock hits 52-week high at 57.87 USD
Rapt Therapeutics-Aktie erreicht 52-Wochen-Hoch bei 57,71 $
Rapt Therapeutics stock reaches 52-week high at $57.71
GSK to Boost Respiratory & Immunology Pipeline With $2.2B RAPT Buyout
Rapt Therapeutics stock hits 52-week high at $57.62